OIIM [O2MICRO INTERNATIONAL] 20-F: (Original Filing)

[2 TABLE OF CONTENTS PART I Item 1. Identity of Directors, Senior Management and Advisors [5] Item 2. Offer Statistics and Expected Timetable [5] Item 3. Key Information [5] Item 4. Information on the Company [14] Item 4A. Unresolved Staff Comments [22] Item 5. Operating and Financial Review and Prospects] [2 Significant Subsidiaries of O 2 2 2 2 2 2 2 2 International Asset Holding Company, a Cayman Islands company] [CERTIFICATION I, Sterling Du, certify that: 1. 2 I have reviewed this annual report on Form 20-F of O 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [CERTIFICATION I, Perry Kuo, certify that: 1. O 2 Micro I have reviewed this annual report on Form 20-F of 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [2 O CERTIFICATION 2 (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Sterling Du Chief Executive Officer Perry Kuo Chief Financial Officer and Principal Accounting Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 We consent to the incorporation by reference in Registration Statement Nos. 333-12670, 333-12672, 333-98425, 333-101452, 333-107975, 333-116596, 333-132251, 333-153436, and 333-162489 on Form S-8 of our reports dated April 25, 2012 relating to the consolidated financial statements of O Deloitte & Touche Taipei, Taiwan Republic of China April 25, 2012]

CO [China Cord Blood] SC 13D: (Original Filing)

[JOINT FILING AGREEMENT [ KKR CHINA HEALTHCARE INVESTMENT LIMITED Richard J. Kreider, Attorney-in-fact for William J. Janetschek, Director KKR CHINA GROWTH FUND L.P.] [Execution Version CONVERTIBLE NOTE PURCHASE AGREEMENT among CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 2 SECTION 2 SALE AND PURCHASE OF THE NOTES 9] [REGISTRATION RIGHTS AGREEMENT between CHINA CORD BLOOD CORPORATION and KKR CHINA HEALTHCARE INVESTMENT LIMITED Dated April 27, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THIS AGREEMENT 5 Section 3 MANDATORY] [Execution Copy DIRECTOR INDEMNIFICATION AGREEMENT between CHINA CORD BLOOD CORPORATION and JULIAN J. WOLHARDT Dated April 27, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Contents Page 1. Interpretation 1 2.] [Execution Copy INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT Agreement Investor KKR Company This INDEMNIFICATION PRIORITY AND INFORMATION SHARING AGREEMENT, dated as of April 27, 2012 (this “ WHEREAS, the Company has entered into a Convertible Note Purchase Agreement dated as of April 12 Company Indemnification Agreement KKR Indemnified Parties , 2012 (the “ KKR Director WHEREAS, one or more executives] [Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and GOLDEN MEDITECH STEM CELL (BVI) COMPANY LIMITED, and GOLDEN MEDITECH HOLDINGS LIMITED Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION 2 RESTRICTIONS] [Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and TING ZHENG Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION 2 RESTRICTIONS ON TRANSFER OF SHARES 4 6] [Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and ALBERT CHEN Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong] [Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and YUE DENG Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION 2 RESTRICTIONS ON TRANSFER OF SHARES 4 6] [Execution Copy LOCK-UP AGREEMENT among KKR CHINA HEALTHCARE INVESTMENT LIMITED and XIN XU Dated April 12, 2012 Paul, Weiss, Rifkind, Wharton & Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OF CONTENTS Page SECTION 1 INTERPRETATION 1 SECTION 2 RESTRICTIONS ON TRANSFER OF SHARES 4 6] [POWER OF ATTORNEY EX-99.11 12 a12-9554_1ex99d11.htm EX-99.11] [POWER OF ATTORNEY EX-99.12 13 a12-9554_1ex99d12.htm EX-99.12] [POWER OF ATTORNEY EX-99.13 14 a12-9554_1ex99d13.htm EX-99.13]

By | 2016-02-29T14:47:21+00:00 May 1st, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

ZX [China Zenix Auto International] SC 13G: (Original Filing)

[CUSIP No. 16951E104 1. Names of Reporting Persons. QVT Financial LP I.R.S. Identification Nos. of above persons (entities only). 11-3694008 2. Check the Appropriate Box if a Member of a Group (See Instructions) ¨ x (a) 3. SEC Use Only 4.]

By | 2016-02-29T21:09:39+00:00 May 1st, 2012|Categories: Chinese Stocks, SEC Original, ZX|Tags: , , , , , |0 Comments

HPJ [Highpower International] 10-K/A: (Original Filing)

[] [Independent Registered Public Accounting Firm’s Consent We consent to the incorporation by reference in the Registration Statement of Highpower International, Inc. and subsidiaries (the “Company”) on Form S-8 (File No.333-157443) and the Registration Statement on Form S-3 (File No. 333-168473) of our report dated March 30, 2012, with respect to our audit of the consolidated financial statements of the Company] [I, Dang Yu Pan, certify that: 1. I have reviewed this annual report on Form 10-K/A of Highpower International, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [I, Henry Sun, certify that: 1. I have reviewed this annual report on Form 10-K/A of Highpower International, Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were]

ZX [China Zenix Auto International] SC 13G: (Original Filing)

[CUSIP No. 16951E104 1. Names of Reporting Persons. QVT Financial LP STYLE="font-family:Times New Roman" SIZE="3"> I.R.S. Identification Nos. ofove persons (entities only). 11-3694008 2. Check the Appropriate Box if a Member of a (See Instructions) (a) 3. SEC Use Only 4. Citizenship or Place of Organization Delaware Numberof Shares]

By | 2016-02-04T22:39:29+00:00 May 1st, 2012|Categories: Chinese Stocks, SEC Original, ZX|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC 13D: (Original Filing)

[JOINT FILINGREEMENT [R CHINA HEALTHCARE INVESTMENT LIMITED Richard J. Kreider, Attorney-in-fact for William J. Janetschek, DirectorR CHINA GROWTH FUND L.P.Rsociates China Growth L.P., its General PartnerR China Growth Limited, its General Partner Richard J. Kreider, Attorney-in-fact for William J. Janetschek, DirectorRSOCIATES CHINA GROWTH L.P.] [Execution VersionNVERTIBLE NOTE PURCHASEREEMENT among CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITEDted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 2 SECTION2LE AND PURCHASE OF THE NOTES] [REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION andR CHINA HEALTHCARE INVESTMENT LIMITEDted April 27, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page Section1 DEFINITIONS 1 Section2 GENERAL; SECURITIES SUBJECT TO THISREEMENT] [Executionpy DIRECTOR INDEMNIFICATIONREEMENT between CHINARD BLOODRPORATION and JULIAN J. WOLHARDTted April 27, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTSntents Page 1. Interpretation 1 2. Indemnity 3 3.] [Executionpy INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENTreement InvestorRmpany This INDEMNIFICATION PRIORITY AND INFORMATION SHARINGREEMENT,ted of April 27, 2012 (this WHEREAS, thempany has entered into anvertible Note Purchasereementted of April 12mpany IndemnificationreementR Indemnified Parties , 2012 (the] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and GOLDEN MEDITECH STEM CELL (BVI)MPANY LIMITED, and GOLDEN MEDITECHS LIMITEDted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and TING ZHENGted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED andBERT CHENted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and YUE DENGted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [Executionpy LOCK-UPREEMENT amongR CHINA HEALTHCARE INVESTMENT LIMITED and XIN XUted April12, 2012 Paul, Weiss, Rifkind, Wharton& Garrison Solicitors and International Lawyers 12th Floor, Hong Kong Club Building 3A Chater Road Central Hong Kong TABLE OFNTENTS Page SECTION1 INTERPRETATION 1 SECTION2 RESTRICTIONS ON TRANSFER OF SHARES 4] [POWER OF ATTORNEY EX-99.11 a12-9554_1ex99d11.htm 12 EX-99.11] [POWER OF ATTORNEY EX-99.12 a12-9554_1ex99d12.htm 13 EX-99.12] [POWER OF ATTORNEY EX-99.13 a12-9554_1ex99d13.htm 14 EX-99.13]

By | 2016-02-04T17:22:26+00:00 May 1st, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 20-F: (Original Filing)

[þ U.S. GAAP International Financial Reporting Standards as issued ¨ by the International Accounting Standards Board ¨ Other ¨ ¨ ¨ þ Page INTRODUCTION 1 PART I 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3 ITEM 4. INFORMATION ON THE COMPANY 27 ITEM 4A.] [LIST OF SUBSIDIARIES • Mindray (UK) Limited, incorporated in the United Kingdom • Mindray Research and Development Limited, incorporated in the British Virgin Islands • Mindray Global Limited, incorporated in the British Virgin Islands • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Beijing Shen Mindray Medical Electronics Technology Research Institute Co., Ltd., incorporated] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Alex Lung, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Xu Hang Chairman and Co-Chief Executive Officer Li Xiting Director, President and Co-Chief Executive Officer Alex Lung Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-178896) of Mindray Medical International Limited of our report dated April 30, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. We also consent to]

Skip to toolbar